
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Sponsored
Sponsored
Sponsored
2026-08-13RGNTSCHEDULE 13GRosalind Advisors Inc. Discloses New 9.9% Stake in Regentis Biomaterials Ltd.HIGH
On August 13, 2026, Rosalind Advisors, Inc., along with Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon, filed a Schedule 13G disclosing a new 9.9% ownership stake in Regentis Biomaterials Ltd. (RGNT). The reporting group beneficially owns a total of 1,428,570 ordinary shares. This position consists of 701,...
Medical Instruments & Suppliesownership +9.90%